Floatz logo

ROPIVACAINE

Gastrointestinal Cancers

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)Small moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
89/ 100

Competitive context

7 Active assets in the Gastrointestinal Cancers cohort.

Asset / SponsorPhaseRating
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
Brian Anderson, MD
Phase 4BB
FAPI74
SOFIE
Phase 2B
ETOPOSIDE
Tianjin First Central Hospital
Phase 1CC
VITAMIN D
Dana-Farber Cancer Institute
Phase 1CC
Igf-Methotrexate Conjugate
IGF Oncology, LLC
Phase 1CC

View all 10 →

Same molecule, other indications

ROPIVACAINE is also rated in:

post-operative pain, non-human animalDormant
BBB
Indicative ·
76 / 100
View asset →
Knee Pain ChronicDormant
BBB
Indicative ·
76 / 100
View asset →
osteoarthritis, hipDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →